BCM
TNDM icon

BlueCrest Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

BlueCrest Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,230
Closed -$396K – 1005
2019
Q1 		$396K Buy
+6,230
New +$327K 0.02% 580
2018
Q2 		– Sell
-173,282
Closed -$859K – 1817
2018
Q1 		$859K Buy
+173,282
New +$559K 0.03% 530

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlueCrest Capital Management's TNDM Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 6,230 shares — an estimated $396K sold.

BlueCrest Capital Management first reported a position in TNDM in Q1 2018 and held it in 2 quarters. The position peaked at $859K in Q1 2018. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 6,230 Tandem Diabetes Care shares in Q2 2019, an estimated $396K.
  • BlueCrest Capital Management first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Tandem Diabetes Care position peaked at $859K in Q1 2018.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.